Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesis
- 31 December 1991
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (2) , 119-121
- https://doi.org/10.1016/0277-5379(91)90466-q
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.Journal of Clinical Oncology, 1989
- Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trialCancer, 1987
- A Log-Linear Model for Binary Cross-Over DataJournal of the Royal Statistical Society Series C: Applied Statistics, 1987
- The Comparison of Success Rates in Cross-Over Trials in the Presence of an Order EffectJournal of the Royal Statistical Society Series C: Applied Statistics, 1981
- 328. Note: The Use of None-Parametric Methods in the Statistical Analysis of the Two-Period Change-Over DesignPublished by JSTOR ,1972